Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arbutus Biopharma Corp (NASDAQ:ABUS)

3.20
Delayed Data
As of Mar 24
 +0.05 / +1.59%
Today’s Change
2.35
Today|||52-Week Range
5.48
+30.61%
Year-to-Date

Today’s Trading

Previous close3.15
Today’s open3.15
Day’s range3.15 - 3.25
Volume59,523
Average volume (3 months)303,764
Market cap$176.1M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-440.30%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-94.01%
P/E ratio--
Price/Sales87.21
Price/Book0.86

Competitors

 Today’s
change
Today’s
% change
MDGLMadrigal Pharmaceuti...-0.01-0.07%
RDHLRedhill Biopharma Lt...+0.11+1.06%
CLSDClearside Biomedical...-0.06-0.84%
FBIOFortress Biotech Inc+0.14+4.05%
Data as of 3:59pm ET, 03/24/2017

Financials

Last reporting dateMarch 22, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$1.5M
Annual profit (last year)-$384.2M
Net profit margin-25,765.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts


Search for Jobs